Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: The PATER study

Current Medical Research and Opinion

Volumn 27, Issue 3, 2011, Pages 569-578

  Costa, S ^a   Venturoli, S ^b   Mennini, F S ^c   Marcellusi, A ^c   Pesaresi, M ^a   Leo, E ^b   Falasca, A ^a   Marra, E ^a   Cricca, M ^b   Santini, D ^a   Zerbini, M ^b   Pelusi, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Borderline cytology; Cervical cancer screening; CIN lesions; HR HPV; LR HPV

Indexed keywords

VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CLINICAL EVALUATION; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; POPULATION RESEARCH; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

EID: 79951637991     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.546730     Document Type: Article

References (39)

1. Giorgi Rossi P, Ricciardi A, Cohet C, et al. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy. BMC Public Health 2009 9:71
2. Coleman D, Day N, Douglas G, et al. European guidelines for quality assurance in cervical cancer screening. Eur J Cancer 1993;29A(Suppl. 4):S1-38
3. Kurman R, Solomon D, Nayar R, et al. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. New York: Springer, 2003
4. Cocchi V, Sintoni C, Carretti D, et al. External quality assurance in cervical/ vaginal cytology: interlaboratory agreement in the Emilia-Romagna region of Italy. Acta Cytol 1996;40:480-8 (Pubitemid 26189680)
5. Solomon D, Schiffman M, Tarone R (for the ALTS study group). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9 (Pubitemid 32219816)
6. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-7 (Pubitemid 24320521)
7. Ronco G, Giorgi Rossi P. New paradigms in cervical cancer prevention: opportunities and risks. BMC Women's Health 2008;8:23
8. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithe-lial neoplasia: a randomised controlled trial. The Lancet Oncology 2010; 11:249-57
9. Arbyn M, Martin-Hirsch P, Buntinx F, et al. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 2009;13:648-59
10. Lynge E, Antilla A, Arbyn M, et al. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer 2009;45:2714-21
11. Arbyn M, Buntinx F, van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasm. J Natl Cancer Inst 2004;96:280-93 (Pubitemid 38256273)
12. Wright Jr TC, Lorincz A, Ferris DG, et al. Reflex human papillomavirus deoxy-ribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998;178:962-6 (Pubitemid 28247170)
13. Szarewski A, Ambroisine L, Cadman L, et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 2008;17:3033-42
14. Ronco G, Cuzick J, Segnan N, et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer 2007;43:476-80 (Pubitemid 46177594)
15. Ronco G, Giubilato P, Naldoni C, et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemiol Prev 2008; 32(2 Suppl. 1):37-54
16. Russo P, Capone A, Attanasio E, et al. Pharmacoutilization and costs of osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice. Rheumatology 2003;42:879-87 (Pubitemid 37220938)
17. Degli Esposti L, Di Martino M, Saragoni S, et al. Pharmacoutilization of statin therapy after acute myocardial infarction. A real practice analysis based on administrative data. Ital Heart J 2004;5:120-6
18. Favato G, Mariani P, Mills RW, et al. ASSET (Age/Sex Standardised Estimates of Treatment): A research model to improve the governance of prescribing funds in Italy. PLoS ONE 2007;2:e592. Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000592 [Last accessed March 2010]
19. Massad LS, Jeronimo J, Katki HA, et al. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009;13:137-44
20. Costa S, Nuzzo MD, Rubino A, et al. Independent determinants of inaccuracy of colposcopically directed punch biopsy of the cervix. Gynecol Oncol 2003;90:57-63 (Pubitemid 37338076)
21. Ferris DG, Litaker MS; for the ALTS Group. Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS. Am J Obstet Gynecol 2006;194:704-10 (Pubitemid 43333143)
22. Musiani M, Venturoli S, Gallinella G, et al. Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. Nat Protoc 2007;2:2502-10
23. Scott DR, Hagmar B, Maddox P, et al. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom. Cancer 2002;96:14-20 (Pubitemid 34194315)
24. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papil-lomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: data from a randomized trial. JNCI 2000; 92:397-402
25. Adelstein AM, Husain OAN, Spriggs AI. Cancer of the cervix and screening. BMJ 1981;282:564
26. Solomon D, Schiffman M, Tarone R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. Obstet Gynecol 2002;99:671-4 (Pubitemid 34246310)
27. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400
28. Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008;123:1864-70
29. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 1:12-19 (Pubitemid 29406813)
30. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5 (Pubitemid 36897943)
31. Klug S, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detection of genital HPV types. J Med Virol 2008; 80:1264-74 (Pubitemid 351706007)
32. Evans M, Adamson C, Papillo JL. Distribution of human papillomavirus types in Thin prep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-64
33. Gupta S, Takhar PP, Degenkolbe R, et al. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofac-tor TRIP-Br1. Virology 2003;317:155-64 (Pubitemid 37522237)
34. Krawczyk E, Suprynowicz FA, Liu X, et al. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 2008;173:682-8
35. Confortini M, Carozzi F, Dalla Palma P, et al. Interlaboratory reproducibility of atypical squamous cells of undetermined significance report: a national survey. Cytopathology 2003;14:263-8 (Pubitemid 37249275)
36. Confortini M, Montanari G, Prandi S. GISCi. Raccomandazioni per il controllo di qualità in citologia cervico vaginale. Epidemiol Prev 2004;28:1-16
37. Mennini FS, Costa S, Favato G, et al. Anti-HPV vaccination: A review of recent economic data for Italy. Vaccine 2009;27:A54-A61
38. Istituto nazionale di statistica (ISTAT) - Fattori di rischio e tutela della salute - Indagine multiscopo sulle famiglie italiane 'Prevenzione dei tumori femminili: ricorso a Pap test e mammografia' anni 2004/2005. Available at: http://www.istat.it/salastampa/comunicati/non-calendario/20061204- 00/2006;2006 [Last accessed March 2010]
39. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72 (Pubitemid 44305665)